COMPLETED

COMPLETED

REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment

Increasing evidence suggests that some immunotherapy dosing regimens for patients with advanced cancer could result in overtreatment. Given the high costs of these agents, and important implications for quality of life and toxicity, new approaches are needed to identify and reduce unnecessary treatment. Conventional two-arm non-inferiority designs are inefficient in this context because they require large numbers of patients to explore a single alternative to the standard of care. REFINE-Lung uses a novel multi-arm multi-stage response over continuous interventions (MAMS-ROCI) design to determine the optimal dose frequency of pembrolizumab. Along with a similarly designed basket study of patients with renal cancer and melanoma, REFINE-Lung and the MAMS-ROCI design could contribute to practice-changing advances in patient care and form a template for future immunotherapy optimisation studies across cancer types and indications. This new trial design is applicable to many new or existing agents for which optimisation of dose, frequency, or duration of therapy is desirable.

Publication

REMOTE ILD trial: remote monitoring of spirometry and pulse oximetry in patients with interstitial lung disease

Remote monitoring of home physiological measurements has been proposed as a solution to support patients with chronic diseases as well as facilitating virtual consultations and pandemic preparedness for the future. Daily home spirometry and pulse oximetry have been demonstrated to be safe and acceptable to patients with interstitial lung disease (ILD) but there is currently limited evidence to support its integration into clinical practice.

Publication 

The value of international health and care workers in the UK

the UK’s proposed “Earned Settlement” immigration reforms could restrict access to permanent residency for around 616,000 overseas health and care workers who arrived between 2022 and 2024.International workers are essential to the NHS and social care, and tighter settlement rules risk worsening existing workforce shortages and undermining continuity and quality of care.

Publication 

Cognitive Behavior Therapy for Depersonalization-Derealization Disorder (CBT-f-DDD)

Depersonalization-derealization disorder (DDD) is characterized by feelings of "unreality" about the self and/or external world. Cognitive Behavioral Therapy adapted for DDD (CBT-f-DDD) has been effective in published clinical audits. This study aimed to provide feasibility and acceptability data.

Publication 

Robotic and conventional total knee arthroplasty

Robotic-arm assisted total knee arthroplasty (RO TKA) has been developed to improve surgical precision and reproducibility compared with conventional techniques. However, the economic implications of adopting robotic technology remain uncertain, particularly within publicly funded healthcare systems. This study aimed to evaluate the in-hospital costs and health-related quality of life outcomes associated with RO TKA compared with conventional TKA (CO TKA) using a cost-utility framework within a UK National Health Service (NHS) institution.

Publication

Value-based orthopaedic surgery : the growing importance of health economics

The paper discusses the growing importance of health economics in orthopaedic surgery, particularly the need to assess the value of surgical interventions rather than focusing solely on clinical outcomes.

Its central theme is value-based care: considering the benefits patients receive in relation to the costs of delivering treatment, to support better-informed clinical and healthcare resource-allocation decisions.

 

Improving Breast Cancer Outcomes by Enhanced Activities in Early Detection and Diagnosis

Variations in short-term breast cancer survival call for promotion of primary prevention, screening, risk awareness and earlier symptomatic presentation. We conducted an umbrella review of published systematic reviews on promotion of screening participation or awareness of and help-seeking behaviours for symptoms with a focus on breast cancer and transferable lessons from the other top five male and female adult cancers in the UK (or other high-income countries with universal healthcare).  Some effective interventions were identified; however, information on inequalities across outcomes and interventions targeting awareness and help-seeking behaviours were limited.

Publication

The Circle of Security Intervention (CoSI) for mothers

A multi-site RCT to explore the clinical and cost effectiveness of the Circle of Security Intervention for mothers in perinatal mental health services

Publication economic evaluation 

Publication trial

Publication protocol

EVIAN: Early Vitrectomy post endophthalmitis

Early Vitrectomy and Intravitreal Antibiotics for post-operative exogenous eNdophthalmitis (EVIAN) study: A feasibility multicentre randomised controlled trial

Publication 

Swallowing prehabilitation for people with head and neck cancer: a pilot cluster-randomised feasibility trial of the SIP SMART intervention

To assess the feasibility of delivering the swallowing prehabilitation intervention known as Swallowing Intervention Package: Self-Monitoring, Assessment and Rehabilitation Training (SIP SMART) within the National Health Service (NHS) head and neck cancer care pathway.

Publication 

International guidelines for the imaging investigation of suspected child physical abuse IGISPA

Radiological imaging is a central facet of the multidisciplinary evaluation of suspected child physical abuse. Current guidelines for the imaging of suspected child physical abuse are often unclear, incomplete and highly variable regarding recommendations on critical questions, thereby risking clinical heterogeneity, unstructured decision-making and missed diagnoses. We, therefore, aim to develop and report an evidence-based and consensus-derived international guideline for the radiological investigation of index and contact children in the context of suspected physical abuse and to ascertain areas of scientific uncertainty to inform future research priorities.

Publication 

VELRAD Videoendoscopic radical inguinal lymphadenectomy versus open radical inguinal lymphadenectomy in penile cancer

VELRAD Videoendoscopic radical inguinal lymphadenectomy versus open radical inguinal lymphadenectomy in patients with penile cancer: a feasibility randomised controlled trial

Evaluating the effectiveness of the alcohol reduction smartphone app, Drink Less, for excessive drinkers in the UK: a randomised controlled trial

Digital interventions are effective for reducing alcohol consumption but evidence is limited regarding smartphone apps. Drink Less is a theory- and evidence-informed app to help people reduce their alcohol consumption that has been refined in terms of its content and design for usability across the socio-demographic spectrum. We aim to evaluate the effectiveness and cost-effectiveness of recommending Drink Less at reducing alcohol consumption compared with usual digital care.

Publication

Publication on engagement

Publication effectiveness

Publication economic evaluation

NeuroSAFE- A single-blinded, multi-centre RCT comparing NeuroSAFE Robot prostatectomy (RALP) to standard RALP

Robot-assisted laparoscopic prostatectomy (RALP) offers potential cure for localised prostate cancer but is associated with considerable toxicity. Potency and urinary continence are improved when the neurovascular bundles (NVBs) are spared during a nerve spare (NS) RALP. There is reluctance, however, to perform NS RALP when there are concerns that the cancer extends beyond the capsule of the prostate into the NVB, as NS RALP in this instance increases the risk of a positive surgical margin (PSM). The NeuroSAFE technique involves intraoperative fresh-frozen section analysis of the posterolateral aspect of the prostate margin to assess whether cancer extends beyond the capsule. There is evidence from large observational studies that functional outcomes can be improved and PSM rates reduced when the NeuroSAFE technique is used during RALP. To date, however, there has been no randomised controlled trial (RCT) to substantiate this finding. The NeuroSAFE PROOF feasibility study is designed to assess whether it is feasible to randomise men to NeuroSAFE RALP versus a control arm of ‘standard of practice’ RALP.

Publication protocol 

Publication trial 

Publication economic evaluation

Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders

The diagnosis of rare diseases and other genetic conditions can be daunting due to vague or poorly defined clinical features that are not recognized even by experienced clinicians. Next-generation sequencing technologies, such as whole-genome sequencing (WGS) and whole-exome sequencing (WES), have greatly enhanced the diagnosis of genetic diseases by expanding the ability to sequence a large part of the genome, rendering a cost-effectiveness comparison between them necessary.

Publication 

TARGIT-B International RCT to compare targeted intra-operative radiotherapy boost for breast cancer

TARGIT-B International RCT to compare targeted intra-operative radiotherapy boost with conventional external beam radiation boost after lumpectomy for breast cancer in women with high risk of local recurrence

Cytoreductive surgery with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care in people with peritoneal metastases

There is uncertainty about whether cytoreductive surgery (CRS)+hyperthermic intraoperative peritoneal chemotherapy (HIPEC) improves survival and/or quality of life compared with standard of care (SoC) in people with peritoneal metastases who can withstand major surgery.

To compare the relative benefits and harms of CRS+HIPEC versus SoC in people with peritoneal metastases from colorectal, ovarian or gastric cancers eligible to undergo CRS+HIPEC by a systematic review and individual participant data (IPD) meta-analysis. To compare the cost-effectiveness of CRS+HIPEC versus SoC from a National Health Service (NHS) and personal social services perspective using a model-based cost–utility analysis.

Publication

Identifying facilitators and barriers to implementation of tumor biopsy pathway for small renal masses (IFIT-B)

Kidney tumours are increasingly detected in patients having investigations for unrelated symptoms. Currently, it is not possible to tell whether a tumour is benign or cancer by a scan, blood or urine test. Most patients diagnosed with a kidney tumour are offered surgery, but this carries serious risks.  Most side effects of biopsies (discomfort, bruising and blood in the urine) resolve without treatment. Nearly 6 in 10 kidney tumours are benign or are low grade (59%), meaning that they are unlikely to cause harm. This means that over half of patients can potentially avoid surgery if they have a biopsy. Currently, access to biopsies is not equal across the UK. We want to find out what the barriers are and what action is required to offer a tumour biopsy service to all patients to help guide treatment decision and improve outcomes.

 

Publication acceptability

Publication protocol 

Projection of the health and economic impacts of Chronic kidney disease in the Chilean population

Chronic Kidney Disease (CKD) is a leading public health problem, with substantial burden and economic implications for healthcare systems, mainly due to renal replacement treatment (RRT) for end-stage kidney disease (ESKD). The aim of this study is to develop a multistate predictive model to estimate the future burden of CKD in Chile, given the high and rising RRT rates, population ageing, and prevalence of comorbidities contributing to CKD.

 

Publication

Publication 2

A feasibility study of a cohort embedded RCT comparing NEphron Sparing Treatment (NEST) for small renal masses

Small renal masses (SRMs; ≤4 cm) account for two-thirds of new diagnoses of kidney cancer, the majority of which are incidental findings. The natural history of the SRM seems largely indolent. There is an increasing concern regarding surgical overtreatment and the associated health burden in terms of morbidity and economy. Observational data support the safety and efficacy of percutaneous cryoablation but there is an unmet need for high-quality evidence on non-surgical management options and a head-to-head comparison with standard of care is lacking. Historical interventional trial recruitment difficulties demand novel study conduct approaches. We aim to assess if a novel trial design, the cohort embedded randomised controlled trial (RCT), will enable carrying out such a comparison.

 

Publication acceptability

Publication trial

COVID-19 welbeing study

The COVID-19 pandemic has resulted in many countries applying restrictive measures, such as lockdown, to contain and prevent further spread. The psychological impact of lockdown and working as a healthcare worker on the frontline has been chronicled in studies pertaining to previous infectious disease pandemics that have reported the presence of depressive symptoms, anxiety, insomnia, and post-traumatic stress symptoms. Potentially linked to psychological well-being and not yet studied is the possibility that lockdown and working on the frontline of the pandemic are associated with perceptions of coercion.

 

Publication 

Health technology assessment of paediatric medicines: European landscape, challenges and opportunities inside the conect4children project

The medicine development process is complex and requires time and effort to ensure safety, efficacy and quality. In paediatrics, this process is even more challenging, as it involves a subgroup of the population that already faces a considerable gap in the clinical evaluation of medicines and devices compared to the adult population. Moreover, access to therapies is heavily influenced by national health technology assessment (HTA) recommendations, which often form the basis for pricing and reimbursement decisions that affect the availability of effective treatments within the national health systems. Yet performing an HTA to assess the relative effectiveness and cost-effectiveness of a new children's treatment has several non-trivial implications, creating a critical issue for the paediatric population. In addition, the advent of innovative health technologies for children emphasises the need to empower the role of HTAs in paediatrics. This article aims at describing the most relevant elements of the drug development process in the paediatric field by focusing on the HTA.

 

Publication

Cost-Effectiveness of the Baveno VI Criteria Compared With Endoscopy for High-Risk Varices in Patients With Child-Pugh A Cirrhosis

Although upper gastrointestinal endoscopy (EGD) remains the gold standard for detecting varices in cirrhosis, the Baveno VI criteria proposed a combination of transient elastography and platelet count that could rule out high-risk varices, therefore sparing the need for an endoscopy, with significant potential cost savings. We performed a cost-effectiveness analysis of the Baveno VI criteria compared with EGD in the diagnosis of high-risk varices in cirrhosis.

Publication 

Treatment of Unresectable Locally Advanced Pancreas Cancer with Percutaneous Irreversible Electroporation Following Initial Systemic Chemotherapy: A Feasibility RCT (LAP-PIE)

Surgery (pancreatic resection) is the only treatment with the potential to cure pancreatic cancer. However only 10 to 20% of people are eligible for surgery. One of the major reasons is that the cancer has spread into the surrounding structures, often the superior mesenteric vein and/or artery. This circumstance affecting about 30% of all patients is termed locally advanced pancreatic cancer (LAPC). Currently, the recommended treatment for LAPC is chemotherapy. Those with a response to chemotherapy would again be considered for resection. Overall 65% of patients post chemotherapy remain with localised but unresectable disease (UK SCALOP trial induction protocol data). Irreversible electroporation (IRE) is a new method of treating localised cancers which are not suitable for surgery. The IRE treatment destroys cancer cells using electricity. Under general anaesthetic the IRE electrodes are inserted into the borders of the pancreas cancer prior to an electrical charge being passed through the cancer. Early studies of IRE in pancreas cancer show that IRE treatment may increase how long people with LAPC live (median survival 25months) but these studies were not controlled or randomised. The improved outcome could therefore be related to patient selection. The aim of this study is to assess the feasibility of performing IRE therapy in patients with locally advanced pancreas cancer (LAPC) whose disease remains locally unresectable following initial chemotherapy.

 

Publication

Evaluating an early social communication intervention for children with Down Syndrome

Down syndrome (DS) is a relatively common genetic condition which affects approximately 1 in every 700 babies. There are approxinmately 38,000 people with DS living in England and Wales. DS is the most common cause of learning disability. Children with DS have particular difficulties with speech and language. This makes it difficult for them to participate fully in life, access health care services and educational opportunities. As DS is detected before or at birth, we can provide support from early on. There are currently no standard interventions for improving the language skills of children with DS under the age of 24 months. Existing research suggests that the earlier an intervention is carried out, the better the outcomes. Evidence also suggests that early parent-based interventions may be effective in improving language outcomes.  Improving the language skills of young children with DS is vital for their future social and emotional well-being and behaviour, and consequently contribution to society. Our aim is to carry out a feasibility study which will inform a future pilot/full trial to test whether the intervention is effective in improving language skills before children with DS start school.

 

Publication protocol

Publication 

Mediterranean diet to prevent type 2 diabetes in women with gestational diabetes: a feasibility study - MERIT

Our aim is to evaluate the effects of a Mediterranean diet, in preventing the development of type 2 diabetes after giving birth, in women with gestational diabetes (GDM). Gestational diabetes is high blood sugar that develops during pregnancy. Before we run a large-scale trial to answer this question, we plan to test the feasibility of running the Mediterranean diet intervention in an NHS setting. Additionally, we will look at the acceptability of the study and interventions, particularly in the postnatal period, to women and healthcare professionals.

 

Publication

Mixed methods evaluation of the Getting it Right First Time programme: improvements to NHS orthopaedic care in England

Orthopaedic procedures, such as total hip replacement and total knee replacement, are among the commonest surgical procedures in England. The Getting it Right First Time project (GIRFT) aims to deliver improvements in quality and reductions in the cost of NHS orthopaedic care across the country. We will examine whether the planned changes have delivered improvements in the quality of care and patient outcomes. We will also study the processes involved in developing and implementing changes to care, and professional and organisational factors influencing these processes. In doing so, we will identify lessons to guide future improvement work in other services.

 

Publication

Do callers follow the advice given by a non-emergency medical helpline (NHS 111)?

National Health Service (NHS) 111 helpline was set up to improve access to urgent care in England, efficiency and cost-effectiveness of first-contact health services. Following trusted, authoritative advice is crucial for improved clinical outcomes. We examine patient and call-related characteristics associated with compliance with advice given in NHS 111 calls. The importance of health interactions that are not face-to-face has recently been highlighted by COVID-19 pandemic. In this retrospective cohort study, NHS 111 call records were linked to urgent and emergency care services data.

Publication

Provision of the NHS 111/Urgent Care Patient Relationship Manager Evaluation

Improving the delivery of urgent and emergency care (UEC) services in London is a main priority of NHS England London. To this aim, NHS England London has implemented the Patient Relationship Manager (PRM) system, a Cloud-based clinical record system, designed to improve patient care by information sharing. It works by assisting in directing NHS 111 calls to the most appropriate health care professional depending on the nature of the call. The economic analysis of the PRM aims to estimate the incremental cost of the service and the potential benefit in economic terms. The expected benefits of the PRM from an economic perspective are the operational efficiencies for both integrated Urgent Care Services, and the wider urgent and emergency care networks. These may translate in changes in the use of Urgent Care Services and the potential saving for the NHS

Obstetric training to reduce OBPI: costs and outcomes (PhD supervision)

Obstetric brachial plexus injuries (OBPIs) are rare but can have significant implications for those affected, their caregivers and the health system. Symptoms can range from restricted movement to complete paralysis of the arm. We investigated health-related quality of life in adults with OBPIs and parents of children with permanent OBPIs, compared these with population norms, and investigated whether certain socio-demographic or clinical factors were associated with the quality of life in these cohorts.

OBPI Quality of Life

The cost of obstetric training

Effectiveness and acceptability of metformin in preventing onset of type 2 diabetes after gestational diabetes in postnatal women - OMAHA

Up to half of all women diagnosed with gestational diabetes mellitus develop type 2 diabetes within 5 years after delivery. Metformin is effective in preventing type 2 diabetes in high-risk non-pregnant individuals, but its effect when commenced in the postnatal period is not known. We plan to assess the feasibility of evaluating metformin versus placebo in minimising the risk of dysglycaemia including type 2 diabetes after delivery in postnatal women with a history of gestational diabetes through a randomised trial.

Publication

Effectiveness and acceptability of myo-inositol nutritional supplement in the prevention of gestational diabetes - EmMY

Gestational diabetes increases maternal and offspring complications in pregnancy and cardiovascular complications in the long term. The nutritional supplement myo-inositol may prevent gestational diabetes; however, further evaluation is required, especially in multiethnic high-risk mothers. Our pilot trial on myo-inositol to prevent gestational diabetes will evaluate trial processes, assess acceptability to mothers and obtain preliminary estimates of effect and cost data prior to a large full-scale trial.

Publication

Endovascular Thrombectomy in Patients with Large Core Ischemic Strokes: a Cost-Utility Analysis from the SELECT Study

Every year, 15 million people worldwide suffer a stroke. Nearly 6 million die and another 5 million are left permanently disabled. For acute ischemic stroke, intravenous recombinant plasminogen activator (IV-tPA) has demonstrated efficacy and cost-effectiveness when administer to eligible patients. However, the prognosis for patients remains disappointing in part because IV-tPA alone is often unable to achieve recanalization, especially when there is a major vessel occlusion. In this case, there is increasing evidence that mechanical thrombectomy has the potential to improve recanalization rates and outcomes for patients with ischemic stroke. We use a Markov model to model the lifetime cost-utility of mechanical thrombectomy compared to IV-tPA alone in the USA.

Publication

Cost-utility analysis of mechanical thrombectomy between 6 and 24 hours in acute ischemic stroke

We compared the cost-utility of mechanical thrombectomy in addition to medical treatment versus medical treatment alone performed beyond 6 h from stroke onset in the UK National Health Service (NHS).

Publication

Cost-effectiveness of a melanoma screening programme using whole disease modelling

A Markov simulation model estimates the cost-effectiveness of a one-time, general practitioner-based melanoma screening strategy in the population aged over 20, compared with no screening. The study considered the most up-to-date drug therapy and was conducted from the perspective of the Veneto regional healthcare system within the Italian National Health Service. Over a 25-year time horizon, the screening intervention dominated usual care. The key drivers of the model were the proportion of melanomas detected by the screening procedure and the adherence of the target population to the screening programme.

Publication

Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease

The identification of patients with advanced liver fibrosis secondary to non-alcoholic fatty liver disease (NAFLD) remains challenging. Using non-invasive liver fibrosis tests (NILT) in primary care may permit earlier detection of patients with clinically significant disease for specialist review, and reduce unnecessary referral of patients with mild disease. We constructed an analytical model to assess the clinical and cost differentials of such strategies.

Our analyses suggest that the use of NILT in primary care can increases early detection of advanced liver fibrosis and reduce unnecessary referral of patients with mild disease and is cost efficient. Adopting a two-tier approach improves resource utilization.

Publication

NIHR CLAHRC North Thames – STAR and diabetes prevention

There are currently 2.6 million people with Type 2 diabetes in England, accounting for just under nine per cent of the annual NHS budget (£8.8 billion a year). There are currently 5 million people in England at high risk of developing Type 2 diabetes and, if current trends persist, one in ten will develop Type 2 diabetes. At this rate, diabetes, pre diabetes and the complications of these conditions would result in a massive increase in the burden of disease and costs of treatment. Evidence shows that prevention is cost-effective for many cases of Type 2 diabetes. But these interventions do not save costs to the NHS. This is because interventions to prevent diabetes can be expensive if sustained for a long period of time, but also because the benefits are relatively short and they translate into savings only in the long term. NIHR CLAHRC North Thames is currently working on a project which aims to review local economies’ plans to prevent diabetes in terms of their scale against the population estimated to be at risk and estimate the cost and impact of those plans.

Valuing Active Life in Dementia

Valuing Active Life in Dementia (VALID) aims to promote independence, meaningful activity and quality of life for people with dementia and their family carers living in the community. We are conducting the economic evaluation of a new form of community occupational therapy for people with dementia and their family carers.

Publication NIHR report

Publication main trial

Impact and experiences of delayed discharge: A mixed‐studies systematic review

We review the current evidence on the impact of delayed discharge on patients, health‐care staff and hospital costs.  Delayed discharge was associated with mortality, infections, depression, reductions in patients’ mobility and their daily activities. The adverse effects of delayed discharge are both direct (through increased opportunities for patients to acquire avoidable ill health) and indirect, secondary to the pressures placed on staff.

NHS Litigation Authority - Economic Evaluation of the Incentivisation Scheme in support of Sign up to Safety

The NHS Litigation Authority (NHS LA) is supporting Sign up to Safety (SuTS), a campaign launched in June 2014 aiming to improve and strengthen the safety of patients in the NHS. As part of the scheme financial incentives have been given to Trusts to reduce harm leading to clinical claims. UCL is conducting the economic evaluation of the scheme to assess the impact of the incentives in reducing errors, incidents and claims in the NHS.

Publication

Does use of point of care testing improve cost effectiveness of the NHS Health Checks programme in the primary care setting? A cost minimisation analysis.

To determine if use of Point of Care Testing (POCT) is less costly than laboratory testing to the NHS in delivering the NHS Heath Check (NHSHC) programme in the primary care setting

Publication 

ABLE - Age of Transfused Blood in Critically Ill Adults

At present red blood cells (RBCs) are stored for up to 42 days prior to transfusion. There is currently insufficient evidence concerning the relative safety of different RBC storage times prior to transfusion in critically ill patients. In this project we assess the clinical and cost-effectiveness of transfusing fresher RBCs (stored for ≤7 days) compared with current standard aged RBCs in critically ill patients requiring blood transfusions.

Publication

Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke

Every year, 15 million people worldwide suffer a stroke. Nearly 6 million die and another 5 million are left permanently disabled. For acute ischemic stroke, intravenous recombinant plasminogen activator (IV-tPA) has demonstrated efficacy and cost-effectiveness when administer to eligible patients. However, the prognosis for patients remains disappointing in part because IV-tPA alone is often unable to achieve recanalization, especially when there is a major vessel occlusion. In this case, there is increasing evidence that mechanical thrombectomy has the potential to improve recanalization rates and outcomes for patients with ischemic stroke. We use a Markov model to model the lifetime cost-utility of mechanical thrombectomy compared to IV-tPA alone in the UK.

Publication

NSPCC – The cost of child maltreatment in the UK

According to NSPCC (2011) child abuse includes “all forms of physical and/or emotional ill-treatment, sexual abuse, neglect or negligent treatment or commercial or other exploitation, resulting in actual or potential harm to the child’s health, survival, development or dignity in the context of a relationship of responsibility, trust or power”. This project has developed the first comprehensive estimates of the costs of child maltreatment in the UK across different short- and long-term outcomes. We used an incidence-based approach to calculate the lifetime costs of child maltreatment.

Report

Publication

 

London Speech and Language TherapyWorkforce Scoping Project

University College London (UCL), in partnership with the Royal College of Speech and Language Therapists (RCSLT), was commissioned by Health Education North Central and East London (HENCEL) to undertake a scoping project of the speech and language therapy (SLT) workforce in London. The project investigated the whole London workforce, including those working outside the NHS to: a) provide a snapshot of the current London SLT workforce; b) estimate the levels of current unmet client need for SLT services in London; and c) predict future unmet need for SLT services in London up to 2025, taking account of a range of variables that might impact future need.

Phase 2: modelling workforce transformation example

We model the impact of a specific technology-based workforce transformation project on the SLT workforce in London. We focus on a novel teleswallowing model for the assessment of swallowing problems in residents of nursing or residential homes, which make up a significant proportion of all referrals to community-based SLT settings.

One size fits all? Mixed methods evaluation of the impact of 100% single-room accommodation on staff and patient experience, safety and costs

There is little strong evidence relating to the impact of single-room accommodation on healthcare quality and safety. We explore the impact of all single rooms on staff and patient experience; safety outcomes; and costs.

Patient and public involvement: how much do we spend and what are the benefits?

Patient and public involvement (PPI) is seen as a way of helping to shape health policy and ensure a patient-focused health-care system. While evidence indicates that PPI can improve health-care decision making, it also consumes monetary and non-monetary resources. Given the financial climate, it is important to start thinking about the costs and benefits of PPI and how to evaluate it in economic terms.

Publication

A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11

Sickle cell disease (SCD) is an inherited blood disorder which may result in a broad range of complications including recurring and severe episodes of pain - sickle “crises” - which require frequent hospitalisations. We assessed the cost of hospitalisations associated with SCD with crisis in England. Methods Hospital Episodes Statistics data for all hospital episodes in England between 2010-2011, recording Sickle Cell Anaemia with Crisis as primary diagnosis were used. The total cost of admissions and exceeded length of stay due to SCD were assessed using the Healthcare Resource Groups ( HRGs) tariffs. The impact of patients’ characteristics on SCD admissions costs and the likelihood of incurring extra bed days were also examined. Results In 2010-2011, England had 6,077 admissions associated with SCD with crisis as primary diagnosis. The total cost for these admissions for commissioners was £18,798,255. The cost of admissions increases with age (children admissions costs 50% less than adults). Patients between 10-19 years old are more likely to stay longer in hospital compare to others. Conclusion SCD represents a significant cost for commissioners and the NHS. Further work is required to assess how best to manage patients in the community, which could potentially lead to a reduction in hospital admissions and length of stay, and their associated costs.

Publication

Screenee perception and health-related quality of life in colorectal cancer screening: A review

Screening for colorectal cancer (CRC) has become established to varying degrees in several Western countries for the past 30 years. Because of its effectiveness, screening has been adopted or is planned in a number of other countries. In most countries, the screening method (e.g., fecal occult blood test [FOBT], sigmoidoscopy) is followed by colonoscopy, for verification. In other countries (e.g., United States, Germany), colonoscopy is the preferred first-line investigation method. However, because colonoscopy is considered to be invasive, might be poorly tolerated, and can be associated with complications, the idea of adopting colonoscopy as the primary screening method suffers. Negative effects of screening methods can reduce participation in programs and thereby negate the desired effect on individual and societal health. At present, there is no generally accepted method either to assess the perception and satisfaction of patients screened or the outcome of the screening procedures in CRC. In this review, we discuss the past development and present availability of instruments to measure health-related quality of life (HRQoL), the scarce studies in which such instruments have been used in screening campaigns, and the findings. We suggest the creation of a specific instrument for the assessment of HRQoL in CRC screening.

Publication

TOP